nodes	percent_of_prediction	percent_of_DWPC	metapath
Nafarelin—Oliguria—Doxorubicin—urinary bladder cancer	0.00248	0.00248	CcSEcCtD
Nafarelin—Pulmonary embolism—Epirubicin—urinary bladder cancer	0.00247	0.00247	CcSEcCtD
Nafarelin—Acute coronary syndrome—Etoposide—urinary bladder cancer	0.00243	0.00243	CcSEcCtD
Nafarelin—Myocardial infarction—Etoposide—urinary bladder cancer	0.00242	0.00242	CcSEcCtD
Nafarelin—Cystitis noninfective—Epirubicin—urinary bladder cancer	0.00241	0.00241	CcSEcCtD
Nafarelin—Neoplasm—Methotrexate—urinary bladder cancer	0.00239	0.00239	CcSEcCtD
Nafarelin—Bladder pain—Methotrexate—urinary bladder cancer	0.00239	0.00239	CcSEcCtD
Nafarelin—Cystitis—Epirubicin—urinary bladder cancer	0.00239	0.00239	CcSEcCtD
Nafarelin—Gynaecomastia—Methotrexate—urinary bladder cancer	0.00236	0.00236	CcSEcCtD
Nafarelin—Coordination abnormal—Doxorubicin—urinary bladder cancer	0.00233	0.00233	CcSEcCtD
Nafarelin—Convulsion—Thiotepa—urinary bladder cancer	0.00232	0.00232	CcSEcCtD
Nafarelin—Alopecia—Gemcitabine—urinary bladder cancer	0.00229	0.00229	CcSEcCtD
Nafarelin—Pulmonary embolism—Doxorubicin—urinary bladder cancer	0.00229	0.00229	CcSEcCtD
Nafarelin—Myalgia—Thiotepa—urinary bladder cancer	0.00228	0.00228	CcSEcCtD
Nafarelin—Arthralgia—Thiotepa—urinary bladder cancer	0.00228	0.00228	CcSEcCtD
Nafarelin—Alopecia—Fluorouracil—urinary bladder cancer	0.00225	0.00225	CcSEcCtD
Nafarelin—Rash maculo-papular—Epirubicin—urinary bladder cancer	0.00225	0.00225	CcSEcCtD
Nafarelin—Bladder pain—Epirubicin—urinary bladder cancer	0.00223	0.00223	CcSEcCtD
Nafarelin—Neoplasm—Epirubicin—urinary bladder cancer	0.00223	0.00223	CcSEcCtD
Nafarelin—Cystitis noninfective—Doxorubicin—urinary bladder cancer	0.00223	0.00223	CcSEcCtD
Nafarelin—Cystitis—Doxorubicin—urinary bladder cancer	0.00221	0.00221	CcSEcCtD
Nafarelin—Alopecia—Cisplatin—urinary bladder cancer	0.00214	0.00214	CcSEcCtD
Nafarelin—Malnutrition—Cisplatin—urinary bladder cancer	0.0021	0.0021	CcSEcCtD
Nafarelin—Anorexia—Thiotepa—urinary bladder cancer	0.00209	0.00209	CcSEcCtD
Nafarelin—Rash maculo-papular—Doxorubicin—urinary bladder cancer	0.00208	0.00208	CcSEcCtD
Nafarelin—Neoplasm—Doxorubicin—urinary bladder cancer	0.00207	0.00207	CcSEcCtD
Nafarelin—Bladder pain—Doxorubicin—urinary bladder cancer	0.00207	0.00207	CcSEcCtD
Nafarelin—Hepatic function abnormal—Epirubicin—urinary bladder cancer	0.00205	0.00205	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Thiotepa—urinary bladder cancer	0.002	0.002	CcSEcCtD
Nafarelin—Eye pain—Epirubicin—urinary bladder cancer	0.00199	0.00199	CcSEcCtD
Nafarelin—Paraesthesia—Thiotepa—urinary bladder cancer	0.00197	0.00197	CcSEcCtD
Nafarelin—Alopecia—Etoposide—urinary bladder cancer	0.00196	0.00196	CcSEcCtD
Nafarelin—Cerebrovascular accident—Methotrexate—urinary bladder cancer	0.00196	0.00196	CcSEcCtD
Nafarelin—Convulsion—Fluorouracil—urinary bladder cancer	0.00192	0.00192	CcSEcCtD
Nafarelin—Myalgia—Gemcitabine—urinary bladder cancer	0.00192	0.00192	CcSEcCtD
Nafarelin—Chest pain—Gemcitabine—urinary bladder cancer	0.00192	0.00192	CcSEcCtD
Nafarelin—Arthralgia—Gemcitabine—urinary bladder cancer	0.00192	0.00192	CcSEcCtD
Nafarelin—Hot flush—Epirubicin—urinary bladder cancer	0.00192	0.00192	CcSEcCtD
Nafarelin—Increased appetite—Epirubicin—urinary bladder cancer	0.00191	0.00191	CcSEcCtD
Nafarelin—Decreased appetite—Thiotepa—urinary bladder cancer	0.0019	0.0019	CcSEcCtD
Nafarelin—Menopausal symptoms—Epirubicin—urinary bladder cancer	0.0019	0.0019	CcSEcCtD
Nafarelin—Hepatic function abnormal—Doxorubicin—urinary bladder cancer	0.0019	0.0019	CcSEcCtD
Nafarelin—Myalgia—Fluorouracil—urinary bladder cancer	0.00189	0.00189	CcSEcCtD
Nafarelin—Chest pain—Fluorouracil—urinary bladder cancer	0.00189	0.00189	CcSEcCtD
Nafarelin—Dysgeusia—Etoposide—urinary bladder cancer	0.00189	0.00189	CcSEcCtD
Nafarelin—Constipation—Thiotepa—urinary bladder cancer	0.00187	0.00187	CcSEcCtD
Nafarelin—Oedema—Gemcitabine—urinary bladder cancer	0.00184	0.00184	CcSEcCtD
Nafarelin—Eye pain—Doxorubicin—urinary bladder cancer	0.00184	0.00184	CcSEcCtD
Nafarelin—Cerebrovascular accident—Epirubicin—urinary bladder cancer	0.00183	0.00183	CcSEcCtD
Nafarelin—Convulsion—Cisplatin—urinary bladder cancer	0.00182	0.00182	CcSEcCtD
Nafarelin—Mood swings—Methotrexate—urinary bladder cancer	0.00182	0.00182	CcSEcCtD
Nafarelin—Oedema—Fluorouracil—urinary bladder cancer	0.00181	0.00181	CcSEcCtD
Nafarelin—Myalgia—Cisplatin—urinary bladder cancer	0.00179	0.00179	CcSEcCtD
Nafarelin—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.00178	0.00178	CcSEcCtD
Nafarelin—Hot flush—Doxorubicin—urinary bladder cancer	0.00177	0.00177	CcSEcCtD
Nafarelin—Increased appetite—Doxorubicin—urinary bladder cancer	0.00177	0.00177	CcSEcCtD
Nafarelin—Affect lability—Epirubicin—urinary bladder cancer	0.00177	0.00177	CcSEcCtD
Nafarelin—Menopausal symptoms—Doxorubicin—urinary bladder cancer	0.00176	0.00176	CcSEcCtD
Nafarelin—Anorexia—Gemcitabine—urinary bladder cancer	0.00176	0.00176	CcSEcCtD
Nafarelin—Urticaria—Thiotepa—urinary bladder cancer	0.00174	0.00174	CcSEcCtD
Nafarelin—Vertigo—Etoposide—urinary bladder cancer	0.00173	0.00173	CcSEcCtD
Nafarelin—Anorexia—Fluorouracil—urinary bladder cancer	0.00173	0.00173	CcSEcCtD
Nafarelin—Oedema—Cisplatin—urinary bladder cancer	0.00172	0.00172	CcSEcCtD
Nafarelin—Mood swings—Epirubicin—urinary bladder cancer	0.0017	0.0017	CcSEcCtD
Nafarelin—Cerebrovascular accident—Doxorubicin—urinary bladder cancer	0.00169	0.00169	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.00168	0.00168	CcSEcCtD
Nafarelin—Convulsion—Etoposide—urinary bladder cancer	0.00167	0.00167	CcSEcCtD
Nafarelin—Insomnia—Gemcitabine—urinary bladder cancer	0.00167	0.00167	CcSEcCtD
Nafarelin—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.00166	0.00166	CcSEcCtD
Nafarelin—Paraesthesia—Gemcitabine—urinary bladder cancer	0.00165	0.00165	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.00165	0.00165	CcSEcCtD
Nafarelin—Dry skin—Epirubicin—urinary bladder cancer	0.00164	0.00164	CcSEcCtD
Nafarelin—Dyspnoea—Gemcitabine—urinary bladder cancer	0.00164	0.00164	CcSEcCtD
Nafarelin—Chest pain—Etoposide—urinary bladder cancer	0.00164	0.00164	CcSEcCtD
Nafarelin—Insomnia—Fluorouracil—urinary bladder cancer	0.00164	0.00164	CcSEcCtD
Nafarelin—Anorexia—Cisplatin—urinary bladder cancer	0.00164	0.00164	CcSEcCtD
Nafarelin—Affect lability—Doxorubicin—urinary bladder cancer	0.00163	0.00163	CcSEcCtD
Nafarelin—Paraesthesia—Fluorouracil—urinary bladder cancer	0.00163	0.00163	CcSEcCtD
Nafarelin—Dyspnoea—Fluorouracil—urinary bladder cancer	0.00161	0.00161	CcSEcCtD
Nafarelin—Decreased appetite—Gemcitabine—urinary bladder cancer	0.0016	0.0016	CcSEcCtD
Nafarelin—Gastritis—Epirubicin—urinary bladder cancer	0.00159	0.00159	CcSEcCtD
Nafarelin—Muscular weakness—Epirubicin—urinary bladder cancer	0.00158	0.00158	CcSEcCtD
Nafarelin—Constipation—Gemcitabine—urinary bladder cancer	0.00158	0.00158	CcSEcCtD
Nafarelin—Decreased appetite—Fluorouracil—urinary bladder cancer	0.00157	0.00157	CcSEcCtD
Nafarelin—Mood swings—Doxorubicin—urinary bladder cancer	0.00157	0.00157	CcSEcCtD
Nafarelin—Asthenia—Thiotepa—urinary bladder cancer	0.00157	0.00157	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.00156	0.00156	CcSEcCtD
Nafarelin—Abdominal distension—Epirubicin—urinary bladder cancer	0.00156	0.00156	CcSEcCtD
Nafarelin—Dysuria—Methotrexate—urinary bladder cancer	0.00155	0.00155	CcSEcCtD
Nafarelin—Pruritus—Thiotepa—urinary bladder cancer	0.00155	0.00155	CcSEcCtD
Nafarelin—Paraesthesia—Cisplatin—urinary bladder cancer	0.00154	0.00154	CcSEcCtD
Nafarelin—Dyspnoea—Cisplatin—urinary bladder cancer	0.00153	0.00153	CcSEcCtD
Nafarelin—Dry skin—Doxorubicin—urinary bladder cancer	0.00152	0.00152	CcSEcCtD
Nafarelin—Hyperhidrosis—Etoposide—urinary bladder cancer	0.00152	0.00152	CcSEcCtD
Nafarelin—Anorexia—Etoposide—urinary bladder cancer	0.0015	0.0015	CcSEcCtD
Nafarelin—Diarrhoea—Thiotepa—urinary bladder cancer	0.0015	0.0015	CcSEcCtD
Nafarelin—Decreased appetite—Cisplatin—urinary bladder cancer	0.00149	0.00149	CcSEcCtD
Nafarelin—Depression—Methotrexate—urinary bladder cancer	0.00147	0.00147	CcSEcCtD
Nafarelin—Gastritis—Doxorubicin—urinary bladder cancer	0.00147	0.00147	CcSEcCtD
Nafarelin—Muscular weakness—Doxorubicin—urinary bladder cancer	0.00146	0.00146	CcSEcCtD
Nafarelin—Dysuria—Epirubicin—urinary bladder cancer	0.00145	0.00145	CcSEcCtD
Nafarelin—Dizziness—Thiotepa—urinary bladder cancer	0.00145	0.00145	CcSEcCtD
Nafarelin—Abdominal distension—Doxorubicin—urinary bladder cancer	0.00144	0.00144	CcSEcCtD
Nafarelin—Urticaria—Fluorouracil—urinary bladder cancer	0.00144	0.00144	CcSEcCtD
Nafarelin—Conjunctivitis—Methotrexate—urinary bladder cancer	0.00144	0.00144	CcSEcCtD
Nafarelin—Paraesthesia—Etoposide—urinary bladder cancer	0.00141	0.00141	CcSEcCtD
Nafarelin—Weight increased—Epirubicin—urinary bladder cancer	0.00141	0.00141	CcSEcCtD
Nafarelin—Weight decreased—Epirubicin—urinary bladder cancer	0.0014	0.0014	CcSEcCtD
Nafarelin—Dyspnoea—Etoposide—urinary bladder cancer	0.0014	0.0014	CcSEcCtD
Nafarelin—Epistaxis—Methotrexate—urinary bladder cancer	0.00139	0.00139	CcSEcCtD
Nafarelin—Vomiting—Thiotepa—urinary bladder cancer	0.00139	0.00139	CcSEcCtD
Nafarelin—Rash—Thiotepa—urinary bladder cancer	0.00138	0.00138	CcSEcCtD
Nafarelin—Dermatitis—Thiotepa—urinary bladder cancer	0.00138	0.00138	CcSEcCtD
Nafarelin—Headache—Thiotepa—urinary bladder cancer	0.00137	0.00137	CcSEcCtD
Nafarelin—Decreased appetite—Etoposide—urinary bladder cancer	0.00137	0.00137	CcSEcCtD
Nafarelin—Constipation—Etoposide—urinary bladder cancer	0.00135	0.00135	CcSEcCtD
Nafarelin—Conjunctivitis—Epirubicin—urinary bladder cancer	0.00134	0.00134	CcSEcCtD
Nafarelin—Dysuria—Doxorubicin—urinary bladder cancer	0.00134	0.00134	CcSEcCtD
Nafarelin—Asthenia—Gemcitabine—urinary bladder cancer	0.00132	0.00132	CcSEcCtD
Nafarelin—Weight increased—Doxorubicin—urinary bladder cancer	0.00131	0.00131	CcSEcCtD
Nafarelin—Epistaxis—Epirubicin—urinary bladder cancer	0.0013	0.0013	CcSEcCtD
Nafarelin—Pruritus—Gemcitabine—urinary bladder cancer	0.0013	0.0013	CcSEcCtD
Nafarelin—Nausea—Thiotepa—urinary bladder cancer	0.0013	0.0013	CcSEcCtD
Nafarelin—Weight decreased—Doxorubicin—urinary bladder cancer	0.0013	0.0013	CcSEcCtD
Nafarelin—Sinusitis—Epirubicin—urinary bladder cancer	0.0013	0.0013	CcSEcCtD
Nafarelin—Pruritus—Fluorouracil—urinary bladder cancer	0.00128	0.00128	CcSEcCtD
Nafarelin—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00126	0.00126	CcSEcCtD
Nafarelin—Urticaria—Etoposide—urinary bladder cancer	0.00125	0.00125	CcSEcCtD
Nafarelin—Rhinitis—Epirubicin—urinary bladder cancer	0.00124	0.00124	CcSEcCtD
Nafarelin—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.00124	0.00124	CcSEcCtD
Nafarelin—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00124	0.00124	CcSEcCtD
Nafarelin—Asthenia—Cisplatin—urinary bladder cancer	0.00123	0.00123	CcSEcCtD
Nafarelin—Epistaxis—Doxorubicin—urinary bladder cancer	0.00121	0.00121	CcSEcCtD
Nafarelin—Sinusitis—Doxorubicin—urinary bladder cancer	0.0012	0.0012	CcSEcCtD
Nafarelin—Dizziness—Fluorouracil—urinary bladder cancer	0.0012	0.0012	CcSEcCtD
Nafarelin—Diarrhoea—Cisplatin—urinary bladder cancer	0.00117	0.00117	CcSEcCtD
Nafarelin—Alopecia—Methotrexate—urinary bladder cancer	0.00117	0.00117	CcSEcCtD
Nafarelin—Vomiting—Gemcitabine—urinary bladder cancer	0.00117	0.00117	CcSEcCtD
Nafarelin—Mental disorder—Methotrexate—urinary bladder cancer	0.00116	0.00116	CcSEcCtD
Nafarelin—Rash—Gemcitabine—urinary bladder cancer	0.00116	0.00116	CcSEcCtD
Nafarelin—Dermatitis—Gemcitabine—urinary bladder cancer	0.00116	0.00116	CcSEcCtD
Nafarelin—Malnutrition—Methotrexate—urinary bladder cancer	0.00115	0.00115	CcSEcCtD
Nafarelin—Headache—Gemcitabine—urinary bladder cancer	0.00115	0.00115	CcSEcCtD
Nafarelin—Vomiting—Fluorouracil—urinary bladder cancer	0.00115	0.00115	CcSEcCtD
Nafarelin—Rhinitis—Doxorubicin—urinary bladder cancer	0.00115	0.00115	CcSEcCtD
Nafarelin—Rash—Fluorouracil—urinary bladder cancer	0.00114	0.00114	CcSEcCtD
Nafarelin—Dermatitis—Fluorouracil—urinary bladder cancer	0.00114	0.00114	CcSEcCtD
Nafarelin—Headache—Fluorouracil—urinary bladder cancer	0.00113	0.00113	CcSEcCtD
Nafarelin—Dysgeusia—Methotrexate—urinary bladder cancer	0.00113	0.00113	CcSEcCtD
Nafarelin—Asthenia—Etoposide—urinary bladder cancer	0.00113	0.00113	CcSEcCtD
Nafarelin—Pruritus—Etoposide—urinary bladder cancer	0.00111	0.00111	CcSEcCtD
Nafarelin—Alopecia—Epirubicin—urinary bladder cancer	0.0011	0.0011	CcSEcCtD
Nafarelin—Nausea—Gemcitabine—urinary bladder cancer	0.00109	0.00109	CcSEcCtD
Nafarelin—Vomiting—Cisplatin—urinary bladder cancer	0.00109	0.00109	CcSEcCtD
Nafarelin—Mental disorder—Epirubicin—urinary bladder cancer	0.00109	0.00109	CcSEcCtD
Nafarelin—Rash—Cisplatin—urinary bladder cancer	0.00108	0.00108	CcSEcCtD
Nafarelin—Dermatitis—Cisplatin—urinary bladder cancer	0.00108	0.00108	CcSEcCtD
Nafarelin—Malnutrition—Epirubicin—urinary bladder cancer	0.00108	0.00108	CcSEcCtD
Nafarelin—Diarrhoea—Etoposide—urinary bladder cancer	0.00108	0.00108	CcSEcCtD
Nafarelin—Nausea—Fluorouracil—urinary bladder cancer	0.00108	0.00108	CcSEcCtD
Nafarelin—Tension—Epirubicin—urinary bladder cancer	0.00106	0.00106	CcSEcCtD
Nafarelin—Dysgeusia—Epirubicin—urinary bladder cancer	0.00106	0.00106	CcSEcCtD
Nafarelin—Nervousness—Epirubicin—urinary bladder cancer	0.00105	0.00105	CcSEcCtD
Nafarelin—Dizziness—Etoposide—urinary bladder cancer	0.00104	0.00104	CcSEcCtD
Nafarelin—Vertigo—Methotrexate—urinary bladder cancer	0.00104	0.00104	CcSEcCtD
Nafarelin—Nausea—Cisplatin—urinary bladder cancer	0.00102	0.00102	CcSEcCtD
Nafarelin—Alopecia—Doxorubicin—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Nafarelin—Mental disorder—Doxorubicin—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Nafarelin—Convulsion—Methotrexate—urinary bladder cancer	0.001	0.001	CcSEcCtD
Nafarelin—Vomiting—Etoposide—urinary bladder cancer	0.001	0.001	CcSEcCtD
Nafarelin—Malnutrition—Doxorubicin—urinary bladder cancer	0.001	0.001	CcSEcCtD
Nafarelin—Rash—Etoposide—urinary bladder cancer	0.000992	0.000992	CcSEcCtD
Nafarelin—Dermatitis—Etoposide—urinary bladder cancer	0.000991	0.000991	CcSEcCtD
Nafarelin—Headache—Etoposide—urinary bladder cancer	0.000985	0.000985	CcSEcCtD
Nafarelin—Arthralgia—Methotrexate—urinary bladder cancer	0.000983	0.000983	CcSEcCtD
Nafarelin—Chest pain—Methotrexate—urinary bladder cancer	0.000983	0.000983	CcSEcCtD
Nafarelin—Myalgia—Methotrexate—urinary bladder cancer	0.000983	0.000983	CcSEcCtD
Nafarelin—Tension—Doxorubicin—urinary bladder cancer	0.000981	0.000981	CcSEcCtD
Nafarelin—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000979	0.000979	CcSEcCtD
Nafarelin—Nervousness—Doxorubicin—urinary bladder cancer	0.000971	0.000971	CcSEcCtD
Nafarelin—Vertigo—Epirubicin—urinary bladder cancer	0.000971	0.000971	CcSEcCtD
Nafarelin—Palpitations—Epirubicin—urinary bladder cancer	0.000955	0.000955	CcSEcCtD
Nafarelin—Convulsion—Epirubicin—urinary bladder cancer	0.000936	0.000936	CcSEcCtD
Nafarelin—Nausea—Etoposide—urinary bladder cancer	0.000934	0.000934	CcSEcCtD
Nafarelin—Myalgia—Epirubicin—urinary bladder cancer	0.00092	0.00092	CcSEcCtD
Nafarelin—Arthralgia—Epirubicin—urinary bladder cancer	0.00092	0.00092	CcSEcCtD
Nafarelin—Chest pain—Epirubicin—urinary bladder cancer	0.00092	0.00092	CcSEcCtD
Nafarelin—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000911	0.000911	CcSEcCtD
Nafarelin—Vertigo—Doxorubicin—urinary bladder cancer	0.000898	0.000898	CcSEcCtD
Nafarelin—Anorexia—Methotrexate—urinary bladder cancer	0.000898	0.000898	CcSEcCtD
Nafarelin—Palpitations—Doxorubicin—urinary bladder cancer	0.000883	0.000883	CcSEcCtD
Nafarelin—Oedema—Epirubicin—urinary bladder cancer	0.000882	0.000882	CcSEcCtD
Nafarelin—Shock—Epirubicin—urinary bladder cancer	0.000867	0.000867	CcSEcCtD
Nafarelin—Convulsion—Doxorubicin—urinary bladder cancer	0.000866	0.000866	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000858	0.000858	CcSEcCtD
Nafarelin—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000852	0.000852	CcSEcCtD
Nafarelin—Insomnia—Methotrexate—urinary bladder cancer	0.000852	0.000852	CcSEcCtD
Nafarelin—Myalgia—Doxorubicin—urinary bladder cancer	0.000851	0.000851	CcSEcCtD
Nafarelin—Chest pain—Doxorubicin—urinary bladder cancer	0.000851	0.000851	CcSEcCtD
Nafarelin—Arthralgia—Doxorubicin—urinary bladder cancer	0.000851	0.000851	CcSEcCtD
Nafarelin—Paraesthesia—Methotrexate—urinary bladder cancer	0.000846	0.000846	CcSEcCtD
Nafarelin—Anorexia—Epirubicin—urinary bladder cancer	0.00084	0.00084	CcSEcCtD
Nafarelin—Dyspnoea—Methotrexate—urinary bladder cancer	0.00084	0.00084	CcSEcCtD
Nafarelin—Decreased appetite—Methotrexate—urinary bladder cancer	0.000819	0.000819	CcSEcCtD
Nafarelin—Oedema—Doxorubicin—urinary bladder cancer	0.000816	0.000816	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000803	0.000803	CcSEcCtD
Nafarelin—Shock—Doxorubicin—urinary bladder cancer	0.000803	0.000803	CcSEcCtD
Nafarelin—Insomnia—Epirubicin—urinary bladder cancer	0.000797	0.000797	CcSEcCtD
Nafarelin—Paraesthesia—Epirubicin—urinary bladder cancer	0.000792	0.000792	CcSEcCtD
Nafarelin—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000789	0.000789	CcSEcCtD
Nafarelin—Dyspnoea—Epirubicin—urinary bladder cancer	0.000786	0.000786	CcSEcCtD
Nafarelin—Anorexia—Doxorubicin—urinary bladder cancer	0.000778	0.000778	CcSEcCtD
Nafarelin—Decreased appetite—Epirubicin—urinary bladder cancer	0.000766	0.000766	CcSEcCtD
Nafarelin—Constipation—Epirubicin—urinary bladder cancer	0.000754	0.000754	CcSEcCtD
Nafarelin—Urticaria—Methotrexate—urinary bladder cancer	0.000748	0.000748	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000743	0.000743	CcSEcCtD
Nafarelin—Insomnia—Doxorubicin—urinary bladder cancer	0.000738	0.000738	CcSEcCtD
Nafarelin—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000733	0.000733	CcSEcCtD
Nafarelin—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000727	0.000727	CcSEcCtD
Nafarelin—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000709	0.000709	CcSEcCtD
Nafarelin—Urticaria—Epirubicin—urinary bladder cancer	0.0007	0.0007	CcSEcCtD
Nafarelin—Constipation—Doxorubicin—urinary bladder cancer	0.000698	0.000698	CcSEcCtD
Nafarelin—Asthenia—Methotrexate—urinary bladder cancer	0.000676	0.000676	CcSEcCtD
Nafarelin—Pruritus—Methotrexate—urinary bladder cancer	0.000667	0.000667	CcSEcCtD
Nafarelin—Urticaria—Doxorubicin—urinary bladder cancer	0.000648	0.000648	CcSEcCtD
Nafarelin—Diarrhoea—Methotrexate—urinary bladder cancer	0.000645	0.000645	CcSEcCtD
Nafarelin—Asthenia—Epirubicin—urinary bladder cancer	0.000633	0.000633	CcSEcCtD
Nafarelin—Pruritus—Epirubicin—urinary bladder cancer	0.000624	0.000624	CcSEcCtD
Nafarelin—Dizziness—Methotrexate—urinary bladder cancer	0.000623	0.000623	CcSEcCtD
Nafarelin—Diarrhoea—Epirubicin—urinary bladder cancer	0.000603	0.000603	CcSEcCtD
Nafarelin—Vomiting—Methotrexate—urinary bladder cancer	0.000599	0.000599	CcSEcCtD
Nafarelin—Rash—Methotrexate—urinary bladder cancer	0.000594	0.000594	CcSEcCtD
Nafarelin—Dermatitis—Methotrexate—urinary bladder cancer	0.000593	0.000593	CcSEcCtD
Nafarelin—Headache—Methotrexate—urinary bladder cancer	0.00059	0.00059	CcSEcCtD
Nafarelin—Asthenia—Doxorubicin—urinary bladder cancer	0.000585	0.000585	CcSEcCtD
Nafarelin—Dizziness—Epirubicin—urinary bladder cancer	0.000583	0.000583	CcSEcCtD
Nafarelin—Pruritus—Doxorubicin—urinary bladder cancer	0.000577	0.000577	CcSEcCtD
Nafarelin—Vomiting—Epirubicin—urinary bladder cancer	0.000561	0.000561	CcSEcCtD
Nafarelin—Nausea—Methotrexate—urinary bladder cancer	0.00056	0.00056	CcSEcCtD
Nafarelin—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000558	0.000558	CcSEcCtD
Nafarelin—Rash—Epirubicin—urinary bladder cancer	0.000556	0.000556	CcSEcCtD
Nafarelin—Dermatitis—Epirubicin—urinary bladder cancer	0.000555	0.000555	CcSEcCtD
Nafarelin—Headache—Epirubicin—urinary bladder cancer	0.000552	0.000552	CcSEcCtD
Nafarelin—Dizziness—Doxorubicin—urinary bladder cancer	0.000539	0.000539	CcSEcCtD
Nafarelin—Nausea—Epirubicin—urinary bladder cancer	0.000524	0.000524	CcSEcCtD
Nafarelin—Vomiting—Doxorubicin—urinary bladder cancer	0.000519	0.000519	CcSEcCtD
Nafarelin—Rash—Doxorubicin—urinary bladder cancer	0.000514	0.000514	CcSEcCtD
Nafarelin—Dermatitis—Doxorubicin—urinary bladder cancer	0.000514	0.000514	CcSEcCtD
Nafarelin—Headache—Doxorubicin—urinary bladder cancer	0.000511	0.000511	CcSEcCtD
Nafarelin—Nausea—Doxorubicin—urinary bladder cancer	0.000485	0.000485	CcSEcCtD
